Current treatment practice and outcomes. Report of the hyponatremia registry
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Current management practices for hyponatremia (HN) are incompletely understood. The HN Registry has recorded diagnostic measures, utilization, efficacy, and outcomes of therapy for eu- or hypervolemic HN. To better understand current practices, we analyzed data from 3087 adjudicated adult patients in the registry with serum sodium concentration of 130 mEq/l or less from 225 sites in the United States and European Union. Common initial monotherapy treatments were fluid restriction (35%), administration of isotonic (15%) or hypertonic saline (2%), and tolvaptan (5%); 17% received no active agent. Median (interquartile range) mEq/l serum sodium increases during the first day were as follows: no treatment, 1.0 (0.0-4.0); fluid restriction, 2.0 (0.0-4.0); isotonic saline, 3.0 (0.0-5.0); hypertonic saline, 5.0 (1.0-9.0); and tolvaptan, 4.0 (2.0-9.0). Adjusting for initial serum sodium concentration with logistic regression, the relative likelihoods for correction by 5 mEq/l or more (referent, fluid restriction) were 1.60 for hypertonic saline and 2.55 for tolvaptan. At discharge, serum sodium concentration was under 135 mEq/l in 78% of patients and 130 mEq/l or less in 49%. Overly rapid correction occurred in 7.9%. Thus, initial HN treatment often uses maneuvers of limited efficacy. Despite an association with poor outcomes and availability of effective therapy, most patients with HN are discharged from hospital still hyponatremic. Studies to assess short- and long-term benefits of correction of HN with effective therapies are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia
Schrier, R. W., Gross, P., Gheorghiade, M., Berl, T., Verbalis, J. G., Czerwiec, F. S., & Orlandi, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa065181 · Cited by 1,215
Self-citationModerate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis
Corona, G., Giuliani, C., Parenti, G., Norello, D., Verbalis, J. G., Forti, G., Maggi, M., & Peri, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080451 · Cited by 301 · cited 2×
“Primary physician specialty, n (%) Nephrologist 104 (3) 82 (5) 10 (1) 8 (1) Endocrinologist 108 (4) 106 (7) 2 (o1) 0 Cardiologist 321 (10) 49 (3) 247 (32) 7 (1) Hepatologist 260 (8) 3 (o1) 4 (1) 246 (39) Oncologist 111 (4) 92 (6) 5 (1) 11 (2) Generalist 1844 (60) 944 (62) 466 (61) 315 (50) Other 338 (11) 247 (16) 28 (…”
Self-citationEpidemiology, pathophysiology, and management of hyponatremic encephalopathy.
Fraser, C. L., & Arieff, A. I. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00274-4 · Cited by 288
Cited by
Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines
Hoorn, E. J., & Zietse, R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101139 · Cited by 368
Metadata
- Authors
- Greenberg, A., Verbalis, J. G., Amin, A. N., Burst, V. R., Chiodo III, J. A., Chiong, J. R., Dasta, J. F., Friend, K. E., Hauptman, P. J., Peri, A., & Sigal, S. H.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 88
- Issue
- 1
- Pages
- 167-177
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1988476274
- Cited by
- 182
- References
- 3
- FWCI
- 16.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.